ABUS

#2131
Arbutus Biopharma Corporation - Common Stock
4.5 6 USD
-0.87%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
4.53
4.58
년간 변동
3.04
5.10
일일 변동
-0.87%
월간 변동
+10.41%
6달 변화
+5.07%
년간 변동율
+33.33%
이전 종가
4.6 0
Open
4.5 7
저가
4.5 3
High
4.5 8
양
635
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 900.77 M
  • Employee 19
  • Founded 2007
  • CEO William H. Collier
  • Website www.arbutusbio.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000RR8V85
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
5.42
주가매출액비율
4.58

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

뉴스